Stifel Nicolaus analyst Derrick Whitfield maintained a Hold rating on AbSci (ABSI – Research Report) today and set a price target of $4.00. The company’s shares opened today at $1.41.
Whitfield covers the Energy sector, focusing on stocks such as PHX Minerals, Clean Energy Fuels, and Marathon Oil. According to TipRanks, Whitfield has an average return of -9.0% and a 37.45% success rate on recommended stocks.
AbSci has an analyst consensus of Strong Buy, with a price target consensus of $6.67.
See today’s best-performing stocks on TipRanks >>
ABSI market cap is currently $134.8M and has a P/E ratio of -1.25.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
AbSci (ABSI) Company Description:
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.
Read More on ABSI: